colleagues retrospectively reviewed the failure pattern of 913 consecutive patients with squamous cell carcinoma of oral cavity cancer (OSCC) and analyzed the risk factors for contralateral neck recurrence (CLRN).
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The 5-year actuarial CLRN rate of 18% in patients with local recurrence (LR) is significantly higher than the 5% in patients with local control (LC). After extensive univariate analyses, the authors separated the patients into 2 groups, LC versus LR, for further subset and multivariate analyses (MVA). MVA suggested that extracapsular spread (ECS) is the only risk for CLRN in LR group. In LC group, separate MVA of 3 subsets of patients: tongue, buccal mucosa, and alveolar ridge, found different sets of risk factors for CLRN for tongue and buccal mucosa patients. Based on the above risk stratification analyses, the authors then recommended a treatment flowchart scheme intended to reduce the incidence of CLNR in OSCC. It all seemed logical but not statistically sound.
The paradox in their risk stratification management flowchart is that a physician has to foresee local control versus local recurrence for a patient before treatment in order to apply the recommended management scheme. Surprisingly, the authors did not have a predictive model for LC versus LR to make the stratification flowchart more believable. To derive a truly clinically applicable treatment flowchart for OSCC, the authors could redo the multivariate analysis of the 2 major subsets of patients, namely tongue cancer and buccal mucosa cancer, regardless of the status of LR and LC.
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